Regulatory Affairs Certification (RAC) 2025 – 400 Free Practice Questions to Pass the Exam

Clinical trials are the cornerstone of the drug development process, as they provide the necessary evidence to evaluate a drug's safety and efficacy before it can be approved for public use. During these trials, the drug is tested on diverse populations under controlled conditions, allowing researchers to observe its effects and any potential side effects. This process not only assesses how well the drug works compared to a placebo or existing treatments but also identifies any adverse reactions that may not have been apparent in earlier stages of research.

The data collected from clinical trials is critical for regulatory bodies, such as the U.S. Food and Drug Administration (FDA), to make informed decisions about whether a drug should be approved for the market. Without comprehensive clinical testing, it would be impossible to ensure that the benefits of a new drug outweigh its risks, which is essential for safeguarding public health.

Other factors such as market demand, advertising strategy, and manufacturing costs, while important to the overall commercial viability of a drug, do not directly impact its safety and effectiveness. These elements come into play after the critical phase of clinical trials has established that a drug is safe and effective for patient use.